Activity value 75International Buyer&Supplier,Last transaction date:
2025-07-22
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for splendid pharmaceutical from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 2 transactions, with a transaction quantity of 5000 and a transaction weight of 0.
YearTransactionsQuantityWeight
20242400000
2025250000
Bill of lading data
<
1/15
>
Trade date
2025/07/22
B/L No.
4878823
Suppliers
splendid pharmaceutical
Buyers
customer no : sp-131305glaxo pharma wholesale ltd kn2 st k igali city market kigali, rwanda em ail id: glaxopharma1@gmail.com cont rwanda act: [+250 784 806 950]
POLs
ahmedabad air
PODs
kigali -
Supply area
India
Purchas area
Rwanda
Weight
——
Amount
47567.78
Hs code
21069099
Product tags
rv,tablet
Product description
SPARVIT - Z 20 EFF.TABLETS
Expand
Trade date
2025/07/22
B/L No.
4878823
Suppliers
splendid pharmaceutical
Buyers
customer no : sp-131305glaxo pharma wholesale ltd kn2 st k igali city market kigali, rwanda em ail id: glaxopharma1@gmail.com cont rwanda act: [+250 784 806 950]
splendid pharmaceutical is International Buyer&Supplier,
and primarily engages in the import and export business of products such as brand name,injection,bran.
According to the 52wmb.com global trade database, as of 2025-07-22, the company has completed 308 international trades,
with its main trading regions covering uganda,rwanda,kenya etc.
The core products include HS30049099,HS30049049,HS30021290 etc,
and its main trading partners are guardian health ltd.kabalagalamuyenga road,glaxo pharma wholesale ltd.,customer no sp.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on splendid pharmaceutical is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.